Guevara-Cervantes JF, Vásquez ME, Canales-Falcón Y, Arenas R

Language: Spanish
References: 21
Page: 194-200
PDF size: 187. Kb.

ABSTRACT

Background: climacteric is a period in women’s life in which ovulation is starts beeing deficient, until the post menopause, it includes pre menopause and menopause. As it is well known, menopause is the permanent and irreversible cessation of menstruation that it is related with physical and psychological manifestations. There is few information about superficial mycotic infections during climacteric.
Objectives: to determine the frequency of superficial mycoses in pre menopause, menopause and post menopause, as well as their clinical varieties and causative agents, and the related comorbidities.
Methodology: A retrospective, descriptive and transversal study was performed at the Mycology Section at “Dr. Manuel Gea González” General Hospital in Mexico City, from 1994 to 2014. Epidemiological and mycological data were collected from 3 743 patients from 40 to 69 years old, as well as their presumptive diagnosis, comorbidities and final diagnosis with their mycological study.
Results: a total of 3 743 patients were studied during 20 years (1994-2014). The most frequent mycoses in pre menopause, menopause and post menopause were onychomycosis (78.8, 84 and 81.4%), tinea pedis (26.4, 25.6 and 22.2%), candidosis (6.3, 7.8 and 8.4%) and tinea corporis (3.8, 4.3 and 3.2%). Among the infections caused by Candida, the most common clinical forms were: interdigital candidosis (38.2, 29.6 and 30.5%), oral (35.1, 45.3 and 42.1%) and folds (21.2, 17.1 and 23.1%). Candida spp. was the most frequently isolated yeast (26.5, 23.4 and 29.7%), and C. albicans in pre menopausal patients (24.4%). The most common presentations of onychomycois were distal and lateral subungual onychomycosis as well as total dystrophic onychomycosis. Main etiologic agents were Trichophyton rubrum and Candida spp.
Conclusions: during climacteric the most common superficial mycoses were onychomycosis and tinea pedis, followed by tinea corporis and candidosis. Their frequency in this stage of the life does not differ from geriatric patients or those with comorbidities such as diabetes and hypertension. The most frequently isolated etiological agents were T. rubrum and Candida spp.

REFERENCES

1. Guerra-Tapia, A., “Menopausia y piel”, Actas DermoSif, 2001, 92: 431-437.

2. Figueroa-Damián, R., “Infecciones más frecuentes en la menopausia”, en Hernández-Valencia, M. y Basavilvazo-Rodríguez, M.A., Menopausia. Cambios fisiopatológicos y atención médica, Prado, México, 2009, 247-261.

3. Kuhle, B.X., “An evolutionary perspective on the origin and ontogeny of menopause”, Maturitas, 2007, 57: 329-337.

4. Meeta, Digumarti L., Agarwal, N., Vaze, N., Shah, R. y Malik, S., “Clinical practice guidelines on menopause: an executive summary and recommendations”, J Midlife Health, 2013, 4: 77-106.

5. Calleja-Agius, J., Brincat, M. y Borg, M., “Skin connective tissue and ageing”, Best Pract Res ClinObstet Gynaecol, 2013, 27: 727-740.

6. inegi, Esperanza de vida al nacimiento según sexo, www.inegi.org.mx, actualizado 15 de abril de 2014.

7. Sharma, S., Tandon, V.R. y Mahajan, A., “Menupausal symptoms in urban women”, JK Science J Med Educ Res, 2007, 13: 2011.

8. Alvarado-García, A., Hernández-Quijano, T., Hernández-Valencia, M. et al., “Guía de práctica clínica. Diagnóstico y tratamiento de la perimenopausia y la posmenopausia”, Rev Med Inst Mex Seguro Soc., 2015, 53 (2): 214-225.

9. Nair, P.A., “Dermatosis associated with menopause”, J Midlife Health, 2014, 5: 168-175.

10. “Guía de la práctica clínica. Atención de los padecimientos ginecológicos más frecuentes de la posmenopausia”, Gobierno Federal, México, 2012: 1-75.

11. Lund, K.J., “Menopause and the menopausal transition”, Med Clin North Am, 2008, 92: 1253-1271.

12. Bruce, D. y Rymer, J., “Symptoms of the menopause”, Best Pract Res Clin Obstet Gynaecol, 2009, 23: 25-32.

13. Lázaro, D., Guillén, F., Novel, V. et al., “Pensando en los pies”, Piel, 2004, 19 (4): 184-190.

14. Gupta, A.K., Jain, H.C., Lynde, C. et al., “Prevalence and epidemiology of unsuspected onychomycosis in patients visiting dermatologists’ offices in Ontario, Canada. A multicenter survey of 2001 patients”, Int J Dermatol, 1997, 36: 783-787.

15. Haneke, E. y Roseeuw, D., “The scope of onychomycosis: epidemiology and clinical features”, Int J Dermatol, 1999, 38 (2): 7-12.

16. Chang, P., “Onicopatías en pacientes geriátricos”, Dermatología Rev Mex, 1995, 39 (1): 28-33.

17. Arenas, R., Micología médica ilustrada, 5a ed., Interamericana-McGraw Hill, México, 2014: 67-98.

18. Saez de Ocariz, M.M., Arenas, R., Ranero-Juárez, G.A. et al., “Frequency of toenailonychomycosis in patients with cutaneous manifestations of chronic venousin sufficiency”, Int J Dermatol, 2001, 40: 18-25.

19. Alvarado, A., Hernández-Álvarez, G., Fernández, R. y Arenas, R., “Onicomicosis por Candida en las uñas de las manos”, Dermatol Rev Mex, 2014, 58: 323-330.

20. Arenas, R., Cedeño, L., Vásquez, E. et al., “Micosis superficiales en geriatría. Estudio retrospectivo de los casos estudiados en 10 años en un hospital de la Ciudad de México”, Dermatol Rev Mex, 2004, 48 (6): 300-306.

21. Castelo-Branco, C. y Fernández-Beroiz, P., “Piel y menopausia: influencia de los estrógenos y del tratamiento hormonal sustitutivo en el envejecimiento cutáneo”, Piel, 2004, 5 (3): 147-153.